Four-week intranasal oxytocin administration reduces attachment avoidance in older women

Horm Behav. 2023 Sep:155:105413. doi: 10.1016/j.yhbeh.2023.105413. Epub 2023 Aug 31.

Abstract

The neuropeptide oxytocin (OT) serves as a critical modulator of social cognition and social behavior. Adult attachment is an affiliative process crucial for social interaction across adulthood. Insecure adult attachment comprises two broad dimensions, attachment anxiety and attachment avoidance. Both these dimensions of attachment are currently understudied regarding OT modulation, and especially in older adults. The present study determined the effects of chronic intranasal OT administration on adult attachment in generally healthy older women and men (aged 55-95 years). Embedded in a larger project, participants were randomly assigned to self-administer 24 international units of either OT or a placebo (P) intranasally twice daily for four weeks. The Experiences in Close Relationships Scale assessed adult attachment (anxiety and avoidance) pre- and post-treatment. There was no significant pre- to post-treatment change in attachment avoidance overall, but the treatment x timepoint x sex interaction was significant, in that women (but not men) in the OT (vs. P) group reported decreased attachment avoidance. No comparable effects were observed for attachment anxiety. Results suggest that older women may benefit from chronic intranasal OT treatment by experiencing less attachment avoidance in their adult relationships.

Keywords: Aging; Anxiety; Attachment; Avoidance; Oxytocin.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Intranasal
  • Adult
  • Aged
  • Anxiety / drug therapy
  • Anxiety Disorders
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Oxytocin*
  • Social Behavior*

Substances

  • Oxytocin